Stock Price
12.73
Daily Change
-5.91%
Yearly
149.61%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 136.78 0.91 0.67% 21.93%
Adma Biologics 1.37 -0.03 -2.14% -38.84%
Agenus 2.84 -0.21 -6.89% -19.09%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 233.83 -1.53 -0.65% -5.82%
AstraZeneca 8,727.00 -43.00 -0.49% 13.01%
Astrazeneca 59.84 0.93 1.58% 13.83%
Biogen 233.81 -5.49 -2.29% -14.62%
BioMarin Pharmaceutical 86.71 -3.51 -3.89% 1.10%
Bristol-Myers Squibb 64.89 -0.04 -0.06% -2.77%
Chimerix 5.62 -0.38 -6.33% -30.62%
Dynavax Technologies 12.73 -0.80 -5.91% 149.61%
Gilead Sciences 70.43 -1.34 -1.87% 5.01%
Glaxosmithkline 46.82 1.29 2.84% 21.48%
GW Pharmaceuticals 218.96 0 0% 108.53%
Idera Pharmaceuticals 0.67 0.01 1.94% -87.65%
Merck & Co 81.54 0.16 0.20% -1.98%
Neurocrine Biosciences 74.50 -3.86 -4.93% -31.51%
Minerva Neurosciences 0.83 -0.01 -0.97% -76.03%
Nektar Therapeutics 11.72 -0.38 -3.14% -31.94%
Novartis 82.10 -0.35 -0.42% -4.00%
Pfizer 54.11 -0.84 -1.53% 47.32%
Regeneron Pharmaceuticals 611.22 -4.02 -0.65% 14.48%
Roche Holding 364.90 -2.45 -0.67% 14.68%
Sarepta Therapeutics 66.12 -4.98 -7.00% -31.69%
TG Therapeutics 14.18 -1.51 -9.62% -71.75%
Vertex Pharmaceuticals 231.07 -2.99 -1.28% -0.36%

Indexes Price Day Year
NASDAQ 14507 -386.86 -2.60% 9.92%
US2000 2096 -66.23 -3.06% -2.55%

Dynavax Technologies
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company that is focused on developing and commercializing novel vaccines. The Company's products include HEPLISAV-B and CpG 1018TM. The HEPLISAV-B is for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The Company also manufactures and sells CpG 1018TM, the adjuvant used in HEPLISAV-B. The Company also engaged in developing CpG 1018 as a premier vaccine adjuvant through research collaborations and partnerships.